Antibiotic use patterns in endoscopic sinus surgery: a survey of the American Rhinologic Society membership.
Christina H Fang, Judd H Fastenberg, Marvin P Fried...
https://pubmed.ncbi.nlm.nih.gov/29334432/Actively Recruiting
Led by Guy's and St Thomas' NHS Foundation Trust · Updated on 2026-06-11
80
Participants Needed
1
Research Sites
N/A
Total Duration
This research evaluates nasal photodisinfection therapy PDT using the Steriwave123 ND System compared to a control group receiving only a photosensitizer formulation in patients undergoing nasal surgery. The study aims to assess the safety and effectiveness of PDT in reducing post-operative complications, especially the need for antibiotics due to surgical site infections. It focuses on patients scheduled for elective nasal surgeries and examines bacterial colonization and mucosal inflammation before and after treatment. Participants are randomly assigned to either receive nasal PDT, involving two applications of a photosensitizer solution activated by light, or control treatment with two swabs of the photosensitizer solution without light activation. Both groups undergo nasal swab cultures and flexible nasendoscopy to assess bacterial presence and inflammation before treatment and about two weeks after surgery. Standard post-operative care is provided to all patients. During the study, participants will have a baseline nasal culture and endoscopic evaluation before surgery, a follow-up in-person review around two weeks after surgery to assess antibiotic use and surgical site infections, and a telephone follow-up at 30 days to monitor antibiotic use and any adverse events. The study measures antibiotic usage, incidence of surgical site infection, nasal bacterial colonization, and mucosal inflammation using specific scoring methods over 30 days following surgery.
CONDITIONS
Assessing the Efficacy of Photodynamic Therapy for Preventing Surgical Site Infections
C
Claire Hopkins
N
Nora Haloob
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Guy's and St Thomas' NHS Foundation Trust
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants receive either nasal photodisinfection therapy involving light-activated photosensitizer applications or control treatment with photosensitizer swabbing without light activation before surgery.
1 visit (pre-operative)
Duration - 30 days post-surgery
Participants undergo nasal cultures and flexible nasendoscopy before and about two weeks after surgery. They also have an in-person review at 2 weeks to assess antibiotic use and surgical site infection and a telephone follow-up at 30 days to review post-operative outcomes.
1 in-person visit and 1 telephone follow-up
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Christina H Fang, Judd H Fastenberg, Marvin P Fried...
https://pubmed.ncbi.nlm.nih.gov/29334432/Sharan J Shah, Vivian S Hawn, Nina Zhu...
https://pubmed.ncbi.nlm.nih.gov/33834876/Philipp Zanger, Dennis Nurjadi, Bernadette Vath...
https://pubmed.ncbi.nlm.nih.gov/21464083/Farzin Khorvash, Fatemeh Abdi, Hessam H Kashani...
https://pubmed.ncbi.nlm.nih.gov/23181229/Heiman F L Wertheim, Damian C Melles, Margreet C Vos...
https://pubmed.ncbi.nlm.nih.gov/16310147/C von Eiff, K Becker, K Machka...
https://pubmed.ncbi.nlm.nih.gov/11136954/Zenildo Santos Silva, Sandra Kalil Bussadori, Kristianne Porta Santos Fernandes...
https://pubmed.ncbi.nlm.nih.gov/26415497/Miraj G Shah-Khan, Jenna Lovely, Amy C Degnim
https://pubmed.ncbi.nlm.nih.gov/22575397/J Davies, D Burke, J R Olliver...
https://pubmed.ncbi.nlm.nih.gov/17172595/M Wainwright, K B Crossley
https://pubmed.ncbi.nlm.nih.gov/12462423/Guy's and St Thomas' NHS Foundation Trust
Lead Sponsor